Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, LifeMD Inc’s stock clocked out at $3.72, up 4.49% from its previous closing price of $3.56. In other words, the price has increased by $4.49 from its previous closing price. On the day, 1.53 million shares were traded. LFMD stock price reached its highest trading level at $3.72 during the session, while it also had its lowest trading level at $3.425.
Ratios:
To gain a deeper understanding of LFMD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.00. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.73. In the meantime, Its Debt-to-Equity ratio is 4.98 whereas as Long-Term Debt/Eq ratio is at 4.47.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on June 18, 2025, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On December 10, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.Mizuho initiated its Neutral rating on December 04, 2024, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when FRIEDEMAN JESSICA bought 20,000 shares for $4.04 per share.
Alvarez Nicholas P sold 75,000 shares of LFMD for $443,760 on Sep 10 ’25. The Chief Acquisition Officer now owns 605,000 shares after completing the transaction at $5.92 per share. On Sep 10 ’25, another insider, Alvarez Nicholas P, who serves as the Officer of the company, bought 75,000 shares for $6.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 179065488 and an Enterprise Value of 163858832. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71 while its Price-to-Book (P/B) ratio in mrq is 131.87. Its current Enterprise Value per Revenue stands at 0.655 whereas that against EBITDA is -120.28.
Stock Price History:
The Beta on a monthly basis for LFMD is 1.45, which has changed by -0.34917736 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $15.84, while it has fallen to a 52-week low of $3.43. The 50-Day Moving Average of the stock is -32.87%, while the 200-Day Moving Average is calculated to be -51.06%.
Shares Statistics:
It appears that LFMD traded 1.21M shares on average per day over the past three months and 2003120 shares per day over the past ten days. A total of 46.58M shares are outstanding, with a floating share count of 39.28M. Insiders hold about 18.40% of the company’s shares, while institutions hold 42.89% stake in the company. Shares short for LFMD as of 1763078400 were 4389291 with a Short Ratio of 3.62, compared to 1760486400 on 4173616. Therefore, it implies a Short% of Shares Outstanding of 4389291 and a Short% of Float of 10.92.
Earnings Estimates
. The current rating of LifeMD Inc (LFMD) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.03, with high estimates of $0.12 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.42 and -$0.23 for the fiscal current year, implying an average EPS of $0.09. EPS for the following year is $0.14, with 2.0 analysts recommending between $0.55 and -$0.26.
Revenue Estimates
In. The current quarter, 8 analysts expect revenue to total $48.57M. It ranges from a high estimate of $58M to a low estimate of $45M. As of. The current estimate, LifeMD Inc’s year-ago sales were $64.25MFor the next quarter, 8 analysts are estimating revenue of $50.07M. There is a high estimate of $58.75M for the next quarter, whereas the lowest estimate is $47.1M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $246.1M, while the lowest revenue estimate was $233.09M, resulting in an average revenue estimate of $236.72M. In the same quarter a year ago, actual revenue was $212.45MBased on 8 analysts’ estimates, the company’s revenue will be $224.04M in the next fiscal year. The high estimate is $249.2M and the low estimate is $197M.
